Ok, now I've read that article in Läkartidningen.
They say that the recomended dose (by the medical company?), 35mg 2-3 times a day, doesn't differ between phenmetrazine and dimetrazine. Also the acute tox. is the same, the central stimulating effect is also the same, registered as the effect on spontanous movement in rats. Later they find that fenmetrazine increases the blood pressure but phendimetrazine doesn't. At first they speculate that this may be because the n-methyl group, but a bit later they mentition that it may be because the phenmetrazine was d,l while the dimetrazine was d-.(!) It seems obvious to me that THAT was the reason it didn't have any blood presure increasing effects, and maybe also why they seem to think it is equipotent.
They also say that phenmetrazine is a metabolite of dimetrazine, with dimetrazine being dominanit in urin samples up to 5 hours after an injection, while phenmetrazine is in majority afterwards. Also there is some n-hydroxy metabolite.
Look up these references to find out for yourself:
Toxicol Appl Pharmacol 2: 589-601 1960: Pharm. and tox. studies of phendimetrazine.
Läkartidningen 1974 Jun 5; 71(23) 2385-2387